Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Brain Research

• Publication date

  1999-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0006-8993(98)01143-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

  1998cited by this paper
• Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species.

  1997cited by this paper
• Brain Microvascular Changes in Alzheimer's Disease and Other Dementias a

  1997cited by this paper
• Amyloid- (cid:98) peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease

  1997cited by this paper
• Tuberculosis in Africa: clinical presentation and management.

  1997cited by this paper
• Amyloid β‐Peptide Induces Cell Monolayer Albumin Permeability, Impairs Glucose Transport, and Induces Apoptosis in Vascular Endothelial Cells

  1997cited by this paper
• Amyloid β‐protein (Aβ) Accumulation in the Leptomeninges during Aging and in Alzheimer Disease

  1997cited by this paper
• TNF-α Opens a Paracellular Route for HIV-1 Invasion across the Blood-Brain Barrier

  1997cited by this paper
• Cerebrovascular endothelial dysfunction mediated by β‐amyloid

  1997cited by this paper
• Effect of tumor necrosis factor-alpha on the permeability of bovine brain microvessel endothelial cell monolayers.

  1997cited by this paper
• Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E

  1997cited by this paper
• beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain.

  1997cited by this paper
• Cerebrovascular pathology in alzheimer's disease

  1997cited by this paper
• Serum interleukin‐6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

  1997cited by this paper
• Interleukin-1 modulates protein tyrosine phosphatase activity and permeability of brain endothelial cells.

  1997cited by this paper
• Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Disease a, b

  1997cited by this paper
• Perivascular astrocytes within Alzheimer's disease plaques.

  1997cited by this paper
• Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain.

  1997cited by this paper
• β-Amyloid-mediated vasoactivity and vascular endothelial damage

  1996cited by this paper
• Cerebral vessels in ageing and Alzheimer's disease.

  1996cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.

  1996cited by this paper
• Scavenging of Alzheimer's amyloid β‐protein by microglia in culture

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs

  1996cited by this paper
• High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice

  1996cited by this paper
• Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.

  1995cited by this paper
• Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-γ

  1995cited by this paper
• In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels ☆

  1995cited by this paper
• Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

  1995cited by this paper
• Amyloid β‐proteins 1—40 and 1—42(43) in the soluble fraction of extra‐ and intracranial blood vessels

  1995cited by this paper
• Amyloid β‐Protein Induces Its Own Production in Cultured Degenerating Cerebrovascular Smooth Muscle Cells

  1995cited by this paper
• Activation of microglial cells by β-amyloid protein and interferon-γ

  1995cited by this paper
• Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood

  1995cited by this paper
• Alzheimer amyloid β‐peptides exhibit ionophore‐like properties in human erythrocytes

  1995cited by this paper
• Heat shock alters Alzheimer's β amyloid precursor protein expression in human endothelial cells

  1994cited by this paper
• Passage of human amyloid β-protein 1–40 across the murine blood-brain barrier

  1994cited by this paper
• Activation of Macrophages by Alzheimer β Amyloid Peptide

  1994cited by this paper
• β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease

  1994cited by this paper
• Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.

  1993cited by this paper
• Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

  1993cited by this paper
• Blood-brain barrier transport of circulating Alzheimer's amyloid beta.

  1993cited by this paper
• The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain.

  1992cited by this paper
• β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

  1992cited by this paper
• The blood-brain barrier and cerebral microcirculation in Alzheimer disease.

  1992cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease.

  1990cited by this paper
• Patterns of gliosis in alzheimer's disease and aging cerebrum

  1989cited by this paper
• Activation of the classical complement pathway in brain tissue of Alzheimer patients.

  1989cited by this paper
• Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

  1989cited by this paper
• Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

  1989cited by this paper
• Protein chemical and immunocytochemical studies of meningovascular beta-amyloid protein in Alzheimer's disease and normal aging.

  1988cited by this paper
• Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• Cerebral amyloid angiopathy. A critical review.

  1987cited by this paper
• The rat brain: A stereotaxic atlas of the forebrain and lower parts of the brain stem

  1986cited by this paper
• ON THE BINDING OF CONGO RED BY AMYLOID

  1962cited by this paper
• The alveolar macrophage

  1960cited by this paper

• Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s Disease and Brain Tumors

  2025cites this paper
• Pinocembrin improves cognition and protects the NVU in Alzheimer related deficits

  2021cites this paper
• VTEX ORCIDs via Evise/Property Store test file 1

  2021cites this paper
• Optimization of Claudin-5 and ICAM-1 protein detection by using capillary-based immunoassay method in human brain endothelial cells

  2021cites this paper
• Relationship Between Amyloid-β Deposition and Blood–Brain Barrier Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Transport of Protein and Antibody Therapeutics Across the Blood–Brain Barrier

  2015cites this paper
• Blood–brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody

  2015cites this paper
• A New Role for Beta-Amyloid in Alzheimer's Disease: Initiation of Thrombotic and Inflammatory Processes Via Coagulation Factor XII and Fibrinogen

  2015cites this paper
• The BBB and BRB in AD

  2015cites this paper
• Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementia

  2014cites this paper
• Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits.

  2014cites this paper
• Obesity and cognitive decline: role of inflammation and vascular changes

  2014cites this paper
• Amyloid-β Interacts with Blood-Brain Barrier Function in Dementia: A Systematic Review

  2013cites this paper
• A Conclusive Review on Amyloid Beta Peptide Induced Cerebrovascular Degeneration and the Mechanism in Mitochondria

  2013cites this paper
• Pathology Associated with AAV Mediated Expression of Beta Amyloid or C100 in Adult Mouse Hippocampus and Cerebellum

  2013cites this paper
• Effects of β-sheet breaker peptides on altered responses of thoracic aorta in rats' Alzheimer's disease model induced by intraamygdaloid Aβ40.

  2013cites this paper
• What causes alzheimer's disease?

  2013cites this paper
• Targeted drug delivery across the blood brain barrier in Alzheimer's disease.

  2013cites this paper
• Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.

  2013cites this paper
• Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.

  2012cites this paper
• Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.

  2012cites this paper
• Transcranial Electromagnetic Treatment Against Alzheimer's Disease: Why it has the Potential to Trump Alzheimer's Disease Drug Development

  2012cites this paper
• Novel Aspects of Nonfasting Lipemia in relation to Vascular Biology

  2012cites this paper
• The functions of the amyloid precursor protein gene.

  2011cites this paper
• The Flavonoid Apigenin Protects Brain Neurovascular Coupling against Amyloid-β25-35-Induced Toxicity in Mice

  2011cites this paper
• A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats

  2011cites this paper
• The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: II Experimental Evidence and Clinical Studies

  2011cites this paper
• Receptor-mediated abeta amyloid antibody targeting to Alzheimer's disease mouse brain.

  2011cites this paper
• Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration.

  2010cites this paper
• IgG‐single chain Fv fusion protein therapeutic for alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey

  2010cites this paper
• Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk.

  2010cites this paper
• The Effects of a High-Energy Diet on Hippocampal Function and Blood-Brain Barrier Integrity in the Rat

  2010cites this paper
• Transport of drugs across the blood-brain barrier in Alzheimer's disease.

  2010cites this paper
• Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice

  2009cites this paper
• Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation

  2009cites this paper
• Amyloid Beta Transport and Effects on Permeability in a Human Brain Endothelial Cell Line

  2009cites this paper
• Alzheimer's disease drug development and the problem of the blood‐brain barrier

  2009cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes.

  2008cites this paper
• Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.

  2008cites this paper
• Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance

  2008cites this paper
• Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers

  2008cites this paper
• Spatial correlations between β-amyloid (Aβ) deposits and blood vessels in familial Alzheimer’s disease

  2008cites this paper
• Chylomicron amyloid-beta in the aetiology of Alzheimer's disease.

  2008cites this paper
• Lipids in Health and Disease

  2008cites this paper
• Apolipoprotein E, Amyloid-&bgr;, and Blood-Brain Barrier Permeability in Alzheimer Disease

  2008cites this paper
• Soluble aggregates of the amyloid‐β protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells

  2007cites this paper
• ALZHEIMER'S DISEASE AND DEMENTIA WITH LEWY BODIES: SPECIAL FOCUS ON THE ROLE OF SERPINS

  2007cites this paper
• Soluble adhesion molecules and angiotensin-converting enzyme in dementia.

  2007cites this paper
• Native and oxidized low-density lipoproteins modulate the vasoactive actions of soluble beta-amyloid peptides in rat aorta.

  2007cites this paper
• Insights into the mechanisms of action of anti‐Aβ antibodies in Alzheimer's disease mouse models

  2006cites this paper
• Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages.

  2006cites this paper
• Effects of adoptive transfer of beta-amyloid sensitive immune cells in a mouse model for Alzheimer's disease

  2005influential citation
• Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex

  2005cites this paper
• Blood-brain barrier transport of cytokines: a mechanism for neuropathology.

  2005cites this paper
• Mechanisms of Soluble β-Amyloid Impairment of Endothelial Function*

  2004cites this paper
• Potentiation of beta-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity.

  2004cites this paper
• Altered CNS response to injury in the MRL/MpJ mouse.

  2004cites this paper
• Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide.

  2004cites this paper
• Hormonal and non-hormonal factors associated with cognition in post-menopausal women

  2004cites this paper
• Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain.

  2003cites this paper
• Canine counterpart of senile dementia of the Alzheimer type: amyloid plaques near capillaries but lack of spatial relationship with activated microglia and macrophages

  2003cites this paper
• Alzheimer vaccine: amyloid-beta on trial.

  2003cites this paper
• Cyclooxygenase-2 expression and activity are induced by amyloid-beta 1-42 in brain derived cells.

  2002cites this paper
• Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease

  2002cites this paper
• Antibodies to β-Amyloid Decrease the Blood-to-Brain Transfer of β-Amyloid Peptide1

  2002cites this paper
• Innate immunity: the missing link in neuroprotection and neurodegeneration?

  2002cites this paper
• Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

  2001cites this paper
• Cerebrovascular structure and dementia: new drug targets.

  2001cites this paper
• The Functions of the Amyloid Precursor Protein Gene

  2001cites this paper
• Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse.

  2000cites this paper
• Designing drugs to stop the formation of prion aggregates and other amyloids.

  2000cites this paper
• Alzheimer’s Disease And Inflammation: A Review Of Cellular And Therapeutic Mechanisms

  2000cites this paper